Image4_Decreasing incidence and mortality of lung cancer in Hungary between 2011 and 2021 revealed by robust estimates reconciling multiple data sources.TIFF by Gabriella Gálffy (177759)

“…Up until the COVID-19 pandemic, lung cancer incidence was decreasing by 3.18% (2.1%–4.3%) yearly in men, while there was no significant decrease in women. …”

Microarray analysis from GEO database showed TNFAIP9 was enhanced in CKD patients and mice. by Ying Chen (9697)

Subjects:

Cumulative effects and geographic distribution of mCHG-decreasing alleles. by Eriko Sasaki (501178)

“…Filled circles indicate mCHH- or mCHG-decreasing alleles. Mapping and statistical testing were performed in R version 3.5.3. …”

Longer polyQ sequences decrease the transcriptional activity of AR. by Carlos M. Roggero (11909585)

Overexpression of TNFAIP9 inhibited the TGF-β-induced fibrosis in HK-2 cells. by Ying Chen (9697)

Subjects:

δPKC activation following OGD decreases Bad phosphorylation via PP2A activation. by Kunjan R. Dave (348112)

Overexpression of TNFAIP9 inhibited the TNF-α-induced inflammation in HK-2 cells. by Ying Chen (9697)

Subjects:

Decrease in invasion of HTR-8/SVneo trophoblastic cells by interferon gamma involves cross-communication of STAT1 and BATF2 that regulates the expression of JUN by Sonam Verma (4818036)

Fig 5 - by Zhe Xu (127066)

Subjects:

Prorocentin-5: A Cytotoxic Polyketide from the Benthic Marine Dinoflagellate <i>Prorocentrum lima</i> by Yunseok Choi (5625245)

Subjects:

Decreased pulmonary cell inflammatory response in FI-A2 and G-A2 peptide vaccinated mice after RSV challenge. by Gertrud U. Rey (501694)

Sequences of the qPCR primers used. by Lucas H. Oronel (8525697)

“…This study aimed to evaluate if AQP2 expression is altered in an adenine-induced model of CKD in rats at early stages of development (two weeks) and to assess a potential beneficial effect of Tolvaptan (a V2 receptor antagonist) treatment. …”

Original and uncropped blots. by Lucas H. Oronel (8525697)

“…This study aimed to evaluate if AQP2 expression is altered in an adenine-induced model of CKD in rats at early stages of development (two weeks) and to assess a potential beneficial effect of Tolvaptan (a V2 receptor antagonist) treatment. …”

A Y45F mutation in hepatitis C virus NS4A causes a decrease in infectious viral titer. by Allison E. Roder (6312761)

Comparison of the decrease of CFU in CSF and blood between treatment groups within the first 6 h after treatment. by Luca G. Valente (12463057)

Fig 5 - by Thiago Bezerra Wanderley e Lima (14232350)

Adverse events in low-dose naltrexone arm. by Judith I. Tsui (5983160)

“…</p><p>Methods</p><p>We conducted a pilot, randomized, double-blinded, 3-arm study of PWH with chronic pain and past-year heavy alcohol use in 2021. …”

CONSORT flow diagram. by Judith I. Tsui (5983160)

“…</p><p>Methods</p><p>We conducted a pilot, randomized, double-blinded, 3-arm study of PWH with chronic pain and past-year heavy alcohol use in 2021. …”

Adverse events in placebo arm. by Judith I. Tsui (5983160)

“…</p><p>Methods</p><p>We conducted a pilot, randomized, double-blinded, 3-arm study of PWH with chronic pain and past-year heavy alcohol use in 2021. …”

Adverse events in gabapentin arm. by Judith I. Tsui (5983160)

“…</p><p>Methods</p><p>We conducted a pilot, randomized, double-blinded, 3-arm study of PWH with chronic pain and past-year heavy alcohol use in 2021. …”